Rosen Law Firm Reminds Myriad Genetics, Inc. Investors of Important Class Action Deadline

NEW YORK, NY– Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Myriad Genetics, Inc. (NASDAQ: MYGN) from August 13, 2014 through March 12, 2018, both dates inclusive (the “Class Period”) of the important June 19, 2018 lead plaintiff deadline in the class action.  The lawsuit seeks to recover damages for Myriad investors under the federal securities laws.

To join the Myriad class action, go to http://rosenlegal.com/cases-1326.html or call Phillip Kim, Esq.

Continue reading Rosen Law Firm Reminds Myriad Genetics, Inc. Investors of Important Class Action Deadline at STL.News.



Source link